Global Branched Stent Grafts Market

Branched Stent Grafts Market Size, Share, Growth Analysis, By Type(Iliac Stent and Others), By Application(EVAR, FEVAR, chimney, others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35G2108 | Region: Global | Published Date: July, 2024
Pages: 157 | Tables: 62 | Figures: 75

Branched Stent Grafts Market News

  • In March 2021, Medtronic collaborated with Spectrum Health to maximise value in healthcare and improve outcomes for patients in West Michigan.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Branched Stent Grafts Market size was valued at USD 303.09 million in 2022 and is poised to grow from USD 327.03 million in 2023 to USD 600.85 million by 2031, growing at a CAGR of 7.90% in the forecast period (2024-2031).

The branched stent grafts market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Bolton Medical', 'Cook Medical', 'Endologix, Inc.', 'Gore Medical', 'JOTEC GmbH', 'LeMaitre Vascular, Inc.', 'Lombard Medical, Inc.', 'Medtronic plc', 'MicroPort Scientific Corporation', 'Nano Endoluminal, S.L.', 'pfm medical', 'QualiMed Innovative Medizinprodukte GmbH', 'Shanghai MicroPort Orthopedics Co., Ltd.', 'Terumo Corporation', 'TriVascular Technologies, Inc.', 'Vascutek, Ltd.', 'W. L. Gore & Associates, Inc.', 'Yinyi Corp', 'Zenith', 'Zhejiang Talent Medical Devices Co., Ltd.'

The rise in the number of endovascular aneurysm repair (EVAR) procedures, improvements in patient care quality, and advancements in medical technology are a few of the major factors that are influencing the branched stent grafts market. Furthermore, an ageing population and a high prevalence of AAA (abdominal aortic aneurysm) are driving growth in the branched stent grafts market.

Abdominal endovascular aneurysm repair (AEVAR), branched endovascular aneurysm repair (BEVAR), and thoracic endovascular aneurysm repair (TEVAR) have all become standard treatments for aneurysms. The majority of people choose these procedures because they are safe, effective, less expensive, and reduce operative time. The success of these procedures is heavily reliant on the use of image guidance techniques such as X-rays.

North America has a largest revenue share. This is because the region has a well-developed healthcare infrastructure, key players, and reimbursement coverage. Furthermore, due to the strong presence of major market players, the regional market is highly competitive. Asia Pacific, on the other hand, is expected to be the fastest-growing regional market, with a CAGR of more over the forecast period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Aortic Stent Grafts Market
Buy Now GET FREE SAMPLE
Stents Market
Buy Now GET FREE SAMPLE
Coronary Stent Market
Buy Now GET FREE SAMPLE
Gastrointestinal Stents Market
Buy Now GET FREE SAMPLE
Vascular Grafts Market
Buy Now GET FREE SAMPLE
Cerebral Vascular Stent Market
Buy Now GET FREE SAMPLE
Stethoscope Market
Buy Now GET FREE SAMPLE
Rhinoplasty Implants Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Branched Stent Grafts Market

Report ID: SQMIG35G2108

$5,300
BUY NOW GET FREE SAMPLE